Results 131 to 140 of about 10,061 (275)

L'amélioration de la situation financière des transports publics urbains est-elle possible ?

, 2009
Cet article vous est proposé avec l'aimable autorisation de l'auteur et de l'éditeur, EDITECOM. La présente version en PDF est sous le copyright d'EDITECOM (http://www.editecom.com/) - 2009.
Faivre D'Arcier, Bruno
core  

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann   +23 more
wiley   +1 more source

Joël Lebreton, Francis Beaucire, Transports publics et gouvernance urbaine

, 2004
de Gayffier Armelle. Joël Lebreton, Francis Beaucire, Transports publics et gouvernance urbaine . In: Recherches et Prévisions, n°75, 2004. pp.
de Gayffier, Armelle
core   +1 more source

Moving ideas: An agenda for expanding the political scope of the policy mobilities approach. [PDF]

Prog Hum Geogr
McCann E.
europepmc   +1 more source

La situation financière des transports publics urbains est-elle « durable » ? [PDF]

L'analyse du financement des transports publics urbains montre depuis de nombreuses années une croissance de la contribution des collectivités publiques, malgré les efforts de développement de l'offre pour en accroître l'usage.
Bruno Faivre D'Arcier
core  

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Transport starter data kit: Historical passenger and freight transport data for selected countries in Africa, Asia, and South America. [PDF]

Data Brief
Tan N, Ambunda R, Medimorec N, Cortez A, Krapp A, Maxwell E, Harrison J, Howells M.   +7 more
europepmc   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Étude de faisabilité du dispositif « Passerelle » couplant transfert monétaire non fléché et orientation sociale destiné à des ménages en situation de précarité en France. [PDF]

Can J Public Health
Gallinari-Safar P, Eymard-Duvernay S, Dubois C, Darmon N, Somaraki M, Hulot M, Souchereau C, Martin E, Ollivier E, Quéau H, Gosset V, Perignon M.   +11 more
europepmc   +1 more source